Mercado global de soluções/diagnóstico de testes de hepatite – Tendências do setor e previsão para 2028

Análise e insights de mercado: Mercado global de solução/diagnóstico de testes de hepatite

Espera-se que o mercado de soluções/diagnóstico de testes de hepatite ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa o mercado para crescer a um CAGR de 4,55% no período de previsão acima mencionado. O aumento da incidência de hepatite em todo o mundo e a necessidade de um sistema de diagnóstico para determinar o tipo de vírus impulsionam o mercado de soluções/diagnóstico de testes de hepatite.

A hepatite é conhecida como inflamação do fígado, que pode ser de diferentes tipos. Distinguem-se ainda os diferentes tipos de vírus, Hepatites A, B e C. O diagnóstico desta doença é feito através de análises ao sangue para cada vírus, existindo também um método de teste de anticorpos relacionados com o vírus. Além disso, existe um método para diagnosticar o tipo de hepatite testando o material genético ou as proteínas do corpo que fazem parte do vírus.

Aumentar a consciencialização sobre os benefícios dos testes do vírus da hepatite ajudando a traçar o curso correto de  tratamento  e prevenção é o fator vital que aumenta o crescimento do mercado, alterando também o estilo de vida e o hábito de consumo alimentar, aumentando o efeito secundário da medicação, o consumo excessivo de álcool, o aumento da incidência de hepatites virais e de doenças autoimunes, o aumento do rendimento disponível dos consumidores, o aumento do turismo médico e a crescente presença de grande demografia da população não diagnosticada são os principais fatores, entre outros , que impulsionam o mercado de soluções/diagnóstico de testes de hepatite. Além disso, o aumento dos avanços tecnológicos e da modernização no sector da saúde, o aumento das actividades de investigação e desenvolvimento no sector da saúde e o aumento dos mercados emergentes com uma base populacional geriátrica crescente criarão ainda mais novas oportunidades para o mercado de soluções /diagnóstico de testes de hepatite no período previsto de 2021. -2028.

However, rising cost of NAT (Nucleic Acid Amplification Testing) and rising lack of any executive compulsory directive issued by the authorities in developing countries regarding the testing for hepatitis virus are the major factors among others which will obstruct the market growth, and will further challenge the growth of hepatitis test solution/diagnosis market in the forecast period mentioned above.

This hepatitis test solution/diagnosis market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on hepatitis test solution/diagnosis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Hepatitis Test Solution/Diagnosis Market Scope and Market Size

Hepatitis test solution/diagnosis market is segmented on the basis of tests, disease type, technology and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of tests, the hepatitis test solution/diagnosis market is segmented into blood tests, imaging tests and liver biopsy.
• Based on disease type, the hepatitis test solution/diagnosis market is segmented into hepatitis B, hepatitis C and other.
• Based on technology, the hepatitis test solution/diagnosis market is segmented into ELISA, rapid diagnostics test, PCR, INAAT and others.
• The hepatitis test solution/diagnosis market is also segmented on the basis of role of end-user into hospitals, diagnostic labs, blood banks, clinics and others.

Hepatitis Test Solution/Diagnosis Market Country Level Analysis

Hepatitis test solution/diagnosis market is analysed and market size insights and trends are provided by country, product type, application and role of administration as referenced above.

The countries covered in the hepatitis test solution/diagnosis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the hepatitis test solution/diagnosis market due to increasing uptake of advanced technologies and the presence of a sophisticated healthcare network in this region.

The country section of the hepatitis test solution/diagnosis market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

Hepatitis test solution/diagnosis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for hepatitis test solution/diagnosis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the hepatitis test solution/diagnosis market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Hepatitis Test Solution/Diagnosis Market Share Analysis

Hepatitis test solution/diagnosis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to hepatitis test solution/diagnosis market.

Os principais players abrangidos no relatório de mercado de solução/diagnóstico de teste de hepatite são F. Hoffmann-La Roche Ltd, Abbott, Bio-Rad Laboratories Inc., Siemens, DiaSorin, QIAGEN, Danaher, bioMérieux SA, Grifols SA, Ortho Clinical Diagnostics, FUJIREBIO Inc., Avantor Inc., Quest Diagnostics Incorporated, MedMira Inc., Laboratory Corporation of America Holdings, Cigna e OraSure Technologies Inc., entre outros players nacionais e globais. Os dados de quota de mercado estão disponíveis para a Global, América do Norte, Europa, Ásia-Pacífico (APAC), Médio Oriente e África (MEA) e América do Sul em separado. Os analistas DBMR compreendem os pontos fortes competitivos e fornecem análises competitivas para cada concorrente em separado.

SKU-27937